Cargando…
Hemospray for recurrent esophageal band ulcer bleeding
Rebleeding after initially successful endoscopic variceal ligation (EVL) occurs in 20-60% of patients, most commonly from band ulcers, and is associated with 20-50% mortality. Although band ulcer bleeding has been treated in a number of different ways, no single therapeutic intervention has shown a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865909/ https://www.ncbi.nlm.nih.gov/pubmed/29594199 http://dx.doi.org/10.5114/ceh.2018.73668 |
_version_ | 1783308769647656960 |
---|---|
author | Sanglodkar, Uday A. Jothimani, Dinesh Rela, Mohamed |
author_facet | Sanglodkar, Uday A. Jothimani, Dinesh Rela, Mohamed |
author_sort | Sanglodkar, Uday A. |
collection | PubMed |
description | Rebleeding after initially successful endoscopic variceal ligation (EVL) occurs in 20-60% of patients, most commonly from band ulcers, and is associated with 20-50% mortality. Although band ulcer bleeding has been treated in a number of different ways, no single therapeutic intervention has shown a clear benefit. Hemospray (Cook Medical, Winston-Salem, North Carolina, USA) is a relatively new non-contact hemostatic modality used in the management of bleeding peptic ulcers. It is a nano-powder that can be sprayed over a larger mucosal area. Here we describe a patient with end stage liver disease who presented with recurrent bleeding from a deep esophageal ulcer following band ligation and sclerotherapy, effectively managed with multiple sessions of Hemospray. |
format | Online Article Text |
id | pubmed-5865909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-58659092018-03-28 Hemospray for recurrent esophageal band ulcer bleeding Sanglodkar, Uday A. Jothimani, Dinesh Rela, Mohamed Clin Exp Hepatol Case Report Rebleeding after initially successful endoscopic variceal ligation (EVL) occurs in 20-60% of patients, most commonly from band ulcers, and is associated with 20-50% mortality. Although band ulcer bleeding has been treated in a number of different ways, no single therapeutic intervention has shown a clear benefit. Hemospray (Cook Medical, Winston-Salem, North Carolina, USA) is a relatively new non-contact hemostatic modality used in the management of bleeding peptic ulcers. It is a nano-powder that can be sprayed over a larger mucosal area. Here we describe a patient with end stage liver disease who presented with recurrent bleeding from a deep esophageal ulcer following band ligation and sclerotherapy, effectively managed with multiple sessions of Hemospray. Termedia Publishing House 2018-02-10 2018-03 /pmc/articles/PMC5865909/ /pubmed/29594199 http://dx.doi.org/10.5114/ceh.2018.73668 Text en Copyright: © 2018 Clinical and Experimental Hepatology http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Case Report Sanglodkar, Uday A. Jothimani, Dinesh Rela, Mohamed Hemospray for recurrent esophageal band ulcer bleeding |
title | Hemospray for recurrent esophageal band ulcer bleeding |
title_full | Hemospray for recurrent esophageal band ulcer bleeding |
title_fullStr | Hemospray for recurrent esophageal band ulcer bleeding |
title_full_unstemmed | Hemospray for recurrent esophageal band ulcer bleeding |
title_short | Hemospray for recurrent esophageal band ulcer bleeding |
title_sort | hemospray for recurrent esophageal band ulcer bleeding |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865909/ https://www.ncbi.nlm.nih.gov/pubmed/29594199 http://dx.doi.org/10.5114/ceh.2018.73668 |
work_keys_str_mv | AT sanglodkarudaya hemosprayforrecurrentesophagealbandulcerbleeding AT jothimanidinesh hemosprayforrecurrentesophagealbandulcerbleeding AT relamohamed hemosprayforrecurrentesophagealbandulcerbleeding |